The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
WisdomTree BioRevolution Fund · Issued by WisdomTree
| MRNA | Moderna Inc | 7.50% |
| TWST | Twist Bioscience Corp | 7.25% |
| LLY | Eli Lilly and Co | 3.54% |
| JNJ | Johnson & Johnson | 2.80% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 2.66% |
| IMNM | Immunome Inc Ordinary Shares | 2.63% |
| NTRA | Natera Inc | 2.49% |
| TEM | Tempus AI Inc Class A common stock | 2.24% |
| DAR | Darling Ingredients Inc | 2.12% |
| UTHR | United Therapeutics Corp | 2.08% |
No recent news for WDNA. The ingest cron pulls every 15 minutes during market hours.